CERE NASDAQ
Cerevel Therapeutics Holdings, Inc.
1W: +1.3%
1M: +9.1%
3M: +5.5%
1Y: +46.7%
3Y: +79.5%
$44.96
Last traded 2024-08-01 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$8M
Revenue
+0.0% YoY
$-460M
Net Income
-17.4% YoY
$-371M
Free Cash Flow
-15.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-92.4%
ROA-44.8%
ROIC-448.0%
Valuation
P/E-16.8
P/B10.8
EV/EBITDA-15.8
Leverage
Debt/Equity0.65
Current Ratio10.22
Interest Cov.-43.6x
Quality Scores
Piotroski F3/9
Altman Z5.76
Beneish M0.00